Lonza Group Ltd

Headquarters: Basel, Switzerland

Employees: 16,218

show_chart SIX: LONN +0.21%

Market Cap

CHF39.13 Billion

CHF as of July 1, 2023

US$43.73 Billion

history Market Cap History

Lonza Group Ltd market capitalization over time

Evolution of Lonza Group Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Lonza Group Ltd

Detailed Description

Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmaceuticals. The Small Molecules division operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. The Cell and Gene division develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies. It also offers contract development and manufacturing services for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment provides specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules and Health Ingredients division offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.


Unlock the Power of Financial AI:

Try Disfold AI Free for 7 Days!

Stocks & Indices

Lonza Group Ltd has the following listings and related stock indices.

Stock: SIX: LONN wb_incandescent



Muenchensteinerstrasse 38

Basel, 4002


Phone: 41 61 316 81 11

Fax: 41 61 316 91 11